Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

heart failure/protease

L'enllaç es desa al porta-retalls
Pàgina 1 des de 342 resultats

Ablation of the stress protease OMA1 protects against heart failure in mice.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Heart failure (HF) is a major health and economic burden in developed countries. It has been proposed that the pathogenesis of HF may involve the action of mitochondria. We evaluate three different mouse models of HF: tachycardiomyopathy, HF with preserved left ventricular (LV) ejection fraction

HIV protease inhibitors that block GLUT4 precipitate acute, decompensated heart failure in a mouse model of dilated cardiomyopathy.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The clinical use of HIV protease inhibitors is associated with insulin resistance and other metabolic changes that increase long-term cardiovascular risk. Since the failing heart has increased reliance on glucose, the influence of drug exposure on glucose homeostasis, myocardial glucose uptake,
BACKGROUND The Inhibition of Metallo Protease by BMS-186716 in a Randomized Exercise and Symptoms Study in Subjects With Heart Failure (IMPRESS) clinical trial randomized patients with congestive heart failure to a daily regimen of either omapatrilat or lisinopril. At 24 weeks, patients randomized
Decreased activity of ADAMTS13, the von Willebrand factor (VWF) cleaving protease, was recently reported in cardiovascular diseases and in hepatic failure. Chronic heart failure (CHF) is characterised by abnormalities of left ventricular function accompanied by the failure of the liver and

Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND Incident heart failure (HF) is increased in persons with human immunodeficiency virus (PHIV). Protease inhibitors (PIs) are associated with adverse cardiac remodeling and vascular events; however, there are no data on the use of PIs in PHIV with HF. OBJECTIVE This study sought to compare

Protease activated receptor-2 contributes to heart failure.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Heart failure is a major clinical problem worldwide. Previous studies have demonstrated an important role for G protein-coupled receptors, including protease-activated receptors (PARs), in the pathology of heart hypertrophy and failure. Activation of PAR-2 on cardiomyocytes has been shown to induce

Role of various proteases in cardiac remodeling and progression of heart failure.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
It is believed that cardiac remodeling due to geometric and structural changes is a major mechanism for the progression of heart failure in different pathologies including hypertension, hypertrophic cardiomyopathy, dilated cardiomyopathy, diabetic cardiomyopathy, and myocardial infarction. Increases

Protease-activated receptor and endothelial-myocyte uncoupling in chronic heart failure.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
We examined the hypothesis that oxidants generated nitroso derivatives, activated latent matrix metalloproteinase (MMP), and induced proteinase-activated receptor 1 (PAR-1), leading to disconnection between the endothelium and myocytes. Administration of cardiospecific tissue inhibitor of
OBJECTIVE To observe myocardial cathepsin (Cat) S expression and activity in hypertensive heart failure rats. METHODS The expression and activity of Cat S were determined in the left ventricular (LV) myocardium (LVM) of Dahl salt-sensitive rats fed either a high-salt (HS, 8%) or low-salt (LS, 0, 3%,

Imaging of infarct healing predicts left ventricular remodeling and evolution of heart failure: focus on protease activity.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos

Digesting the remodeled heart: role of lysosomal cysteine proteases in heart failure.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos

Coagulation, protease-activated receptors, and viral myocarditis.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The coagulation protease cascade plays an essential role in hemostasis. In addition, a clot contributes to host defense by limiting the spread of pathogens. Coagulation proteases induce intracellular signaling by cleavage of cell surface receptors called protease-activated receptors (PARs). These

Role of proteases in the pathophysiology of cardiac disease.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Cardiovascular disease is a major cause of death and thus a great deal of effort has been made in salvaging the diseased myocardium. Although various factors have been identified as possible causes of different cardiac diseases such as heart failure and ischemic heart disease, there is a real need

Molecular basis of calpain cleavage and inactivation of the sodium-calcium exchanger 1 in heart failure.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Cardiac sodium (Na(+))-calcium (Ca(2+)) exchanger 1 (NCX1) is central to the maintenance of normal Ca(2+) homeostasis and contraction. Studies indicate that the Ca(2+)-activated protease calpain cleaves NCX1. We hypothesized that calpain is an important regulator of NCX1 in response to pressure

[New pharmaceuticals in cardiology. Heart failure, anticoagulation, dyslipidemia].

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Three innovative pharmaceuticals which might play an important role in the field of cardiology in the near future were recently tested in large clinical studies. Serelaxin, a vasoactive hormone peptide that is produced during pregnancy, reduces vessel resistance, increases cardiac output, and
Uneix-te a la nostra
pàgina de Facebook

La base de dades d’herbes medicinals més completa avalada per la ciència

  • Funciona en 55 idiomes
  • Cures a base d'herbes recolzades per la ciència
  • Reconeixement d’herbes per imatge
  • Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
  • Llegiu publicacions científiques relacionades amb la vostra cerca
  • Cerqueu herbes medicinals pels seus efectes
  • Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades

Google Play badgeApp Store badge